Put companies on watchlist
aap Implantate AG
ISIN: DE000A3H2101
WKN: A3H210
Curious about what AI knows about aap Implantate? Just one click more
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

aap Implantate AG · ISIN: DE000A3H2101 · EQS - adhoc news (102 News)
Country: Germany · Primary market: Germany · EQS NID: 2009105
15 October 2024 11:25PM

Möglicher Cyber-Angriff auf aap


EQS-Ad-hoc: aap Implantate AG / Schlagwort(e): Sonstiges
aap Implantate AG: Möglicher Cyber-Angriff auf aap

15.10.2024 / 23:25 CET/CEST
Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News - ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.


 

Die aap Implantate AG (die „Gesellschaft“) hat am 15. Oktober 2024 festgestellt, dass es einen möglichen Cyberangriff auf die IT-Systeme der Gesellschaft gegeben hat. Die Gesellschaft hat als Reaktion die Systeme proaktiv vom Internet getrennt, um Datenschutzverletzungen und Datenbeschädigungen zu verhindern. Die IT-Systeme sowie der Umfang der Auswirkungen werden aktuell überprüft. Dabei wird mit höchster Sorgfalt auf die Datenintegrität geachtet.



 

Kontakt:
Bei Rückfragen wenden Sie sich bitte an:
aap Implantate AG; R. Di Girolamo; Vorsitzender des Vorstands / CEO; Lorenzweg 5; D-12099 Berlin
Tel.: +49/30/750 19 – 170; Fax: +49/30/750 19 – 290; r.digirolamo@aap.de


Ende der Insiderinformation

15.10.2024 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter https://eqs-news.com


Sprache: Deutsch
Unternehmen: aap Implantate AG
Lorenzweg 5
12099 Berlin
Deutschland
Telefon: +49 (0) 30 75 019-0
Fax: +49 (0) 30 75 019-111
E-Mail: info@aap.de
Internet: www.aap.de
ISIN: DE000A3H2101
WKN: A3H210
Börsen: Regulierter Markt in Frankfurt (General Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart, Tradegate Exchange
EQS News ID: 2009105

 
Ende der Mitteilung EQS News-Service

2009105  15.10.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2009105&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - aap Implantate AG
Smart analysis and research tools can be found here.
MIC: XETR

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.